Evidence map›Paper›PMID 29896801›Full record

ArticleDiabetes, obesity & metabolism2018

High-fat-diet-induced remission of diabetes in a subset of K

Zihan Yan, Zeenat A Shyr, Manuela Fortunato, Alecia Welscher, Mariana Alisio, Michael Martino, Brian N Finck, Hannah Conway, Maria S Remedi

Open access · greenAbstract read
In one paragraph

Article in Diabetes, obesity & metabolism, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.9field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Effects of rosuvastatin on metabolic profile: Versatility of dose-dependent effect.Journal of advanced pharmaceutical technology & research
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Zihan YanDepartment of Medicine, Division of Endocrinology, Metabolism and Lipid Research, Washington University School of Medicine, St Louis, Missouri.
Zeenat A ShyrDepartment of Medicine, Division of Endocrinology, Metabolism and Lipid Research, Washington University School of Medicine, St Louis, Missouri.
Manuela FortunatoDepartment of Medicine, Division of Endocrinology, Metabolism and Lipid Research, Washington University School of Medicine, St Louis, Missouri.
Alecia WelscherDepartment of Medicine, Division of Endocrinology, Metabolism and Lipid Research, Washington University School of Medicine, St Louis, Missouri.
Mariana AlisioDepartment of Medicine, Division of Endocrinology, Metabolism and Lipid Research, Washington University School of Medicine, St Louis, Missouri.
Michael MartinoDepartment of Medicine, Division of Geriatrics and Nutritional Science, Washington University School of Medicine, St Louis, Missouri.
Brian N FinckDepartment of Medicine, Division of Geriatrics and Nutritional Science, Washington University School of Medicine, St Louis, Missouri.
Hannah ConwayDepartment of Medicine, Division of Endocrinology, Metabolism and Lipid Research, Washington University School of Medicine, St Louis, Missouri.
Maria S RemediDepartment of Medicine, Division of Endocrinology, Metabolism and Lipid Research, Washington University School of Medicine, St Louis, Missouri.ORCID 0000-0003-2048-472X
Washington University in St. Louis · US

Funding

Washington University Nutrition Obesity Research CenterP30DK056341 · NIDDK · WASHINGTON UNIVERSITY · PI Dominic N Reeds · 1999 to 2026
$30.2M
WU P&FP30DK020579 · NIDDK · WASHINGTON UNIVERSITY · PI Clay F. Semenkovich · 2013 to 2026
$27.1M
TARGETING THE MITOCHONDRIAL PYRUVATE CARRIER TO TREAT NONALCOHOLIC STEATOHEPATITISR01DK104735 · NIDDK · WASHINGTON UNIVERSITY · PI FINCK, BRIAN N · 2015 to 2025
$7.1M
BETA-CELL EXHAUSTION AND GLUCOTOXICITY IN DIABETESR01DK098584 · NIDDK · WASHINGTON UNIVERSITY · PI REMEDI, MARIA SARA · 2013 to 2017
$1.7M
Imaging, Modeling and Engineering of Diabetic TissuesT32DK108742 · NIDDK · WASHINGTON UNIVERSITY · PI NICHOLS, COLIN G · 2016 to 2020
$1.4M
Beta-Cell Exhaustion and Glucotoxicity in DiabetesR56DK098584 · NIDDK · WASHINGTON UNIVERSITY · PI REMEDI, MARIA SARA · 2019 to 2019
$117k
NIDDK NIH HHS P30 DK020579NIDDK NIH HHS P30 DK056341NIDDK NIH HHS R01 DK098584NIDDK NIH HHS R01 DK104735NIDDK NIH HHS R56 DK098584NIDDK NIH HHS T32 DK108742NIH HHS 098584NIH HHS 104735
6 · The paper itself

Abstract

aimsTo examine the effects of a high-fat-diet (HFD) on monogenic neonatal diabetes, without the confounding effects of compensatory hyperinsulinaemia.

methodsMice expressing K

resultsSurprisingly, K

conclusionTogether, our results suggest that restriction of dietary carbohydrates and caloric replacement by fat can induce metabolic changes that are beneficial in reducing glucotoxicity and secondary consequences of diabetes in a mouse model of insulin-secretory deficiency.

Indexed as

Diet, High-FatGain of Function MutationAnimalsCells, CulturedDiabetes Mellitus, ExperimentalFemaleGene Knock-In TechniquesInsulin ResistanceInsulin-Secreting CellsKcnj11 ChannelMaleMiceMice, TransgenicObesityOrgan SpecificityPotassium Channels, Inwardly RectifyingKcnj11 ChannelPotassium Channels, Inwardly Rectifyingglucose metabolismhigh fat dietinsulin resistanceinsulin secretionisletsβ-cell function

Identifiers

PMID29896801
PMCPMC6407888
OpenAlexW2808611130

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.